Format

Send to

Choose Destination
Cancer Cell. 2019 Mar 18;35(3):341-343. doi: 10.1016/j.ccell.2019.02.012.

Therapeutic Clues from an Integrated Omic Assessment of East Asian Triple Negative Breast Cancers.

Author information

1
Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97201, USA.
2
Department of Cell, Development and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
3
Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97201, USA. Electronic address: grayjo@ohsu.edu.

Abstract

In this issue of Cancer Cell, Jiang et al. report a genomic and transcriptional analysis of triple negative breast cancers (TNBCs) from an East Asian population. Their study shows minor differences with published studies of European and North American populations and suggests a therapeutic decision tree for treatment of TNBC.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center